相似文献
1
Discontinuing anticytomegalovirus therapy in patients with cytomegalovirus retinitis and AIDS.
Br J Ophthalmol. 2001 Apr;85(4):381-2. doi: 10.1136/bjo.85.4.381.
2
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Surv Ophthalmol. 2000 Mar-Apr;44(5):455.
3
Suspension of anticytomegalovirus maintenance therapy following immune recovery due to highly active antiretroviral therapy.
Br J Ophthalmol. 2001 Apr;85(4):471-3. doi: 10.1136/bjo.85.4.471.
4
Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy.
Am J Ophthalmol. 1998 Dec;126(6):817-22. doi: 10.1016/s0002-9394(98)00285-2.
5
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
JAMA. 1999 Nov 3;282(17):1633-7. doi: 10.1001/jama.282.17.1633.
6
Immune recovery uveitis.
Am J Ophthalmol. 2000 Jul;130(1):103-6. doi: 10.1016/s0002-9394(00)00537-7.
7
Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.
Am J Ophthalmol. 2000 Jul;130(1):49-56. doi: 10.1016/s0002-9394(00)00530-4.
8
Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Am J Ophthalmol. 2002 Jan;133(1):48-61. doi: 10.1016/s0002-9394(01)01322-8.
9
Active cytomegalovirus retinitis after the start of antiretroviral therapy.
Br J Ophthalmol. 2019 Feb;103(2):157-160. doi: 10.1136/bjophthalmol-2018-312406. Epub 2018 Sep 8.
10
Five-year follow-up of a cohort of profoundly immunosuppressed patients discontinuing therapy for cytomegalovirus retinitis.
AIDS. 2004 Feb 20;18(3):567-9. doi: 10.1097/00002030-200402200-00027.
Zotero 插件